An evidence-based review of ACE inhibitors in incipient diabetic nephropathy

Canadian Journal of Clinical Pharmacology

Volumn 7, Issue 2, 2000, Pages 115-119

  Haider, A ^a   Oh, P ^a   Peloso, P M ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Angiotensin converting enzyme inhibitors; Diabetic nephropathy; Evidence based review; Microalbuminuria; Normotensive diabetics

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

BLOOD PRESSURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; MICROALBUMINURIA; REVIEW;

EID: 0033834660     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Population comparisons of the frequency of diabetic nephropathy
2. Kidney disease of diabetes mellitus (diabetic nephropathy): Perspectives in the United States
3. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
4. Do ACE inhibitors prevent progression of renal disease in normotensive diabetics with microalbuminuria? A meta-analysis of randomized controlled trials
5. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy
6. The effect of angiotensin converting enzyme inhibitor on diabetic nephropathy
7. Course of renal disease in Pima Indians with non-insulin dependent diabetes mellitus
8. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin dependent diabetes
9. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
10. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus
11. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non insulin dependent diabetes mellitus: A randomized prospective 6 year study
12. The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control
13. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria
14. Prevention of diabetic renal disease with special reference to microalbuminuria
15. X. Urinary albumin excretion over 3 years in diet-treated type 2 diabetic patients, and association with hypertension, hyperglycemia and hypertriglyceridemia
16. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus
17. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes
18. The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus. A systematic overview of the literature
19. 1998 Clinical practice guidelines for the management of diabetes in Canada
20. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin dependent diabetes mellitus
21. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?
22. Screening to prevent renal failure in insulin dependent diabetic patients: An economic evaluation
23. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria
24. Effect of captopril on progression to clinical proteinuria in patients with insulin dependent diabetes mellitus and microalbuminuria
25. The beneficial effect of angiotensin converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
26. Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
27. Long term renoprotective effect of angiotensin converting enzyme inhibition in non insulin dependent diabetes mellitus. 7 Year follow up study
28. Effects of long term enalapril treatment on persistent microalbuminuria in normotensive type II diabetic patients - Results of a four year prospective, randomized study
29. Randomised placebo controlled trial of lisinopril in normotensive patients with insulin dependent diabetes and normoalbuminuria or microalbuminuria
30. Use of enalapril to attenuate decline in renal function in normotensive normoalbuminuric patients with type 2 diabetes mellitus
31. Risk factors for development of incipient and overt nephropathy in patients with NIDDM: Prospective, observational study